WinstonWınston
USANA Health Sciences logo

USANA Health Sciences

USNA
54
Medical - Pharmaceuticals · Consumer Defensive
Winston Score
54
Winston is curious
Mixed quality — meaningful strengths and weaknesses.

USANA Health Sciences makes vitamins, nutritional supplements, and weight management products. Its customers are everyday consumers who want to improve their health, and it sells brands like USANA Essentials and Reset. The company competes in the global dietary supplements industry, which is crowded with both large consumer brands and smaller wellness companies.

USANA sells its products almost entirely through a direct sales model, meaning independent distributors buy and resell the products rather than stores. It operates in roughly 25 markets, with Asia-Pacific — especially China — generating the majority of its revenue. The direct sales model creates loyalty among its distributor network, but it also creates risk: regulatory pressure on direct selling in China has hurt the business before, and continued weakness in that market remains the key challenge the company faces going forward.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

YoY Growth Rate

Revenue data limited

EPS Growth

YoY Growth Rate

EPS data limited

Insider Activity

46.6%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~6 years

$158M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

$158M cash & investments at current burn rate

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
78.2%
Premium pricing power — 78.2% gross margin
Operating Margin
7.6%
Modest — 7.6% operating margin
ROCE
3.2%
Weak — 3.2% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+5.7%
Slow sales growth (5.7% YoY)
EPS YoY
-74.2%
Earnings shrinking (-74.2% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
187%
Turns 187% of profit into real cash
FCF Margin
0.3%
Thin free cash flow (0.3%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.03
Conservative — low debt load (0.03)
Interest Cover
73.12x
Comfortably covers interest (73.1x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
47.1x
no trend
Expensive — P/E 47.1

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward
+37.2
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (47.1 → 9.9)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial